Axera
Formulation
Each vial contains:
Cefepime (as hydrochloride) 500 mg, 1 g, or 2 g

Cefepime HCl

Axera®

Prescription Drug

Indication

For the treatment of the following infections caused by susceptible microorganisms:

  • Lower respiratory tract infections, including pneumonia (moderate to severe) and bronchitis
  • Uncomplicated and complicated urinary tract infections (UTIs), including pyelonephritis
  • Skin and skin structure infections
  • Complicated intra-abdominal infections, including peritonitis and biliary tract infections
  • Empiric therapy for febrile neutropenic patients
  • Septicemia

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.